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The Aerospace Medical
Elective
First aerospace medical elective in
Arizona given birth by physician
BY DAVID BRYMAN, D.O.

A
Tamisiea Award. Dr. Manuel Rico Jaime (center),
receives the 2003 Tamisiea plaque from CAMA
President Dr. Robin E. Dodge (right) and AsMA
President Dr. Claude Thibeault.
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This year's recipient of CAMA's top
award, the Tamisiea Memorial Award, went
to Brig. Gen. Victor Manuel Rico Jaime,
M.D., "for his contribution in the application of the art and science of aviation medicine and to general and commercial aviation over the past 22 years..." Dr. Rico Jaime
designed and implemented a primary course
in aviation medicine for military and civilian AMEs in Mexico. He serves as an AME
for both Mexico and the US Federal Aviation Administration.
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r THE DECEMBER 2002 CAMA Board
neeting in Dallas, Dr. Dodge proposed
that the board members consider contacting
their local medical schools to discuss the possibility of offering medical students some lectures in Aerospace Medicine. The idea of introducing students to this subject was to
broaden their educational experience and
pique their interest in choosing Aerospace
Medicine as a career.
Designing and implementing an aerospace curriculum intrigued me. I contacted
Dr. McWilliams, Associate Dean of Midwestern University at the Arizona College
of Osteopathic Medicine and presented him
with a formal proposal and course outline.
The curriculum committee met shortly
thereafter and unanimously approved the
Continued on page 5
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'TT'he FAA flight physical: If it were a per-L son rather than a concept, it would truly
have my sympathy! It was doomed to unpopularity from the beginning.
Think about it! It's mandatory. It costs
money. And the government regulates it. If
that weren't enough, the findings from this

physical could swiftly bring an end to
anyone's flying career or avocation. As
AMEs or flight surgeons, we are called upon
to perform this physical exam and use our
findings to ultimately decide on three possible courses of action: deny, defer, or issue.
Continued on page 4
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Medical
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THE
PRESIDENT'S THOUGHTS

is an exciting time to be
a leader or member of a
premier aeromedical association whose membership
is on the front lines*

OR SEVERAL REASONS, I feel
that the effort expended to
rebuild CAMA and its in-

frastructure over the last decade

position on the issue. The Board

is showing signs of success.

confirmed that the press release,

1— CAMA is better known now

BY ROBIN E. DODGE, MD

as posted on our Web site, reflects

so that when it is mentioned in a

our position and that it is not a

conversation, it does not evoke a

medical issue.

blank stare.

The r e c e n t SARS o u t b r e a k

2—The number and type of con-

The c u r r e n t CAMA gover-

combined with the depressed eco-

tacts or requests received at the

nance team does not condone the

nomic circumstances of the air-

Home Office. A number of these

status quo as an acceptable atti-

lines, has created conditions ripe

are from sources that have not

tude. Improving, updating, and

for major stress. This is particu-

previously been in the habit of

developing new a p p r o a c h e s —

larly important for the Aviation

dealing with CAMA.

while ensuring that current solid

Medical Examiner when dealing

3— The CAMA Sunday session

practices are maintained—are the

with his airline pilot clientele.

held in conjunction with the an-

essential elements in moving an

The AME must be leery of the

nual Aerospace Medical Associa-

organization forward.

effect(s) that these stressors might

tion scientific meeting.

To this end, at the Board of

have on the pilot's health.

The second a n n u a l CAMA

Trustees meeting in San Antonio,

All in all, it is a busy time to

Sunday was recently held in San

an updated draft of CAMA's con-

be involved with the aeromedical

Antonio. The quality of the

s t i t u t i o n and by-laws was re-

aspects of flight safety. However,

speakers who agreed to give pre-

viewed. Also, an ad hoc commit-

it is also an exciting time to be a

sentations and their general posi-

tee was created and tasked to look

leader or member of a premier

tive response to the event after-

into productive ways to engage

aeromedical association whose

wards speaks well for CAMA.

fellow medical associations in

membership is on the front lines.

This also indicates the planning

meaningful dialogue about the

So, if you are not yet a mem-

orchestrated by Dr. Jack Hastings,

role of f r o n t - l i n e , primary-care

ber of the Civil Aviation Medical

was a professional effort.

physicians in dealing with the ill

Association, visit our Web site's

and injured flying public.

application page—

We would like to see the audience grow a little faster, and are

The Age 60 Rule continues to

working on an improved advance

simmer along, coming to a boil

notification system for next year

periodically. Just prior to the re-

when the CAMA Sunday will be

cent Board meeting, CAMA was

in Anchorage, Alaska.

asked to comment on its current

http://civilavmed.com/ap.htm
and become an active CAMA
team member.
Have a good, healthy, and safe
summer.

FP
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I

t is a pleasure to report the health of
our organization. We continue to
flourish. Our membership status continues to increase and the financial stability of the organization remains quite
healthy. All CAMA-supported and directed educational programs and activities are on-line and excellently managed.
Your management team needs some
input, particularly in the SecretaryTreasurer position, due to the illness
of the current owner of that chair.
However, your President is making
steps in that direction.
Next, of particular recognition, is the
success of CAMA Sunday scientific session, coordinated yearly with the annual
Aerospace Medical Association meeting.
Should it be possible, CAMA should
further investigate mutual support in the
meetings and programs sponsored by the
Airline Medical Directors Association.
In conclusion, it's been quite satisfactory to watch the progress of CAMA's
dedicated management team over the
last year. The future of the association
continues to look bright and secure.
Newsletter Progress
This year, the Civil Aviation Medical Association's Flight Physician has
been the source of challenges, interest,
perseverance, and a few hard knocks!
Meeting deadlines of issues for the newsletter every two months has been a rewarding experience and has resulted in
a very active voice for your membership,
as well as outside aviation authorities.
I have recommended that the
editorship of the CAMA Flight Physician be jointly served by both the appointed editor and the president-elect,
with both terms to last concurrently and
terminate at the end of the presidentelect's two-year term. In such a format,

a greater appreciation of the mechanics
of publishing the newsletter will be
shared through the editor to the president-elect.
The president-elect will support the
newsletter by actively contributing articles. Such rotation of duties of dual
editorship of the newsletter on a two-year
basis should result in "hopefully" a fresher
turnover of ideas, editorials, aviation articles, and membership stimulus. A
strong emphasis will consistently be
needed in the securing of advertisements
for the newsletter.
Most importantly, our biggest "editorin-the-sky" — Executive Vice-President
Jim Harris — is to be recognized as the
greatest contributor to your Flight
Physician's success!
Dr. Bryman New Co-Editor
A positive change is anticipated because Dr. David
Bryman is now
your Flight Physician co-editor.
David is a prolific
writer and has
now begun lecturing an aerospace medicine
course (which he
Dr. Bryman
developed) as an
elective program
at Midwestern University in Phoenix, as
well as teaching in the graduate and undergraduate programs at Embry-Riddle
Aeronautical University [see Aerospace
Medical Elective, page 1].
Dr. Bryman is one of CAMA's active
younger members with plenty of writing
capability. Please help him along with
your written article contributions.
FP
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Over my short years of AME
work, I have, from time to time,
made a few pilots very unhappy with
my choice of action in all three categories. Lest you think it impossible
to upset a pilot with the issuance of
a valid medical certificate, I recount
the following tale: Captain Heavy
(whose name is fictitious, but which
suggest nicely the type of equipment
he flew, not to mention his habitus)
came to me with mild asthma. Oh,
this was no new problem. He'd had
mild symptoms for years, but his
asthma had been well controlled with
an acceptable medication. This time
however, things were different.
"Doc," he said, "I think I want to
hang it up. I think I'll use my asthma
to get an early retirement." After
pulmonary function studies revealed
that his asthma had definitely not
worsened and, in fact, was better than
ever, he was very unhappy.
"What if I quit taking my medicine? Would that do it?" he asked. I
explained to him that there were,
theoretically, many things one could
do to achieve medical disqualification. Self-inflicted injury or the intentional mismanagement of a condition or disease or even the fabrication of symptoms would be possible,
but such course of action would be
unwise on two counts.
First, it could compromise his
health, and second it would be relatively easy to detect. It would also be
dishonest and would necessitate falsifying at least two documents: the
FAA form 8500-8, and the disability
forms from his airline.
Captain Heavy was somewhat less
than exuberant over my interpretation of Western ethics, but he conceded, "The risks would be too
great..." (This was, of course, his
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interpretation of Western ethics and
perhaps a more popular one at that.)
The lessons here are simple. When
disability is involved, keep a modicum of suspicion and quantify all that
you can. When there is a question as
to the validity of a complaint, you
don't have to confront or preach. Do
what I should have done. Just say
those magic words, "Well, we'll send
all this in to the boys in Oklahoma
City and see what they say."
One of the most tempting traps
to fall into is what I call "certification on the come." That is when you
issue a certificate on good faith expecting a hard copy confirmation of
something or other. An example (regrettably from my own files) follows:
Sid Stone (not his real name, but
if I tell you Sid was short for residual,
it will begin to make sense later)
called the office late one afternoon
desperately needing a second-class
flight physical. We agreed to "work
him in," and so he was the last thing
for me between a hard day and a hot
dinner.
When I reviewed his history on
the front of the Form 8500-8, I noticed 18J was checked and "kidney
stone 2 years ago" was written in the
comments field below it. Sid explained, "I had a pain in the right
side of my back, so I went to my family doctor, and he did an X-ray. Later
that night, the stone passed. I went
back to the doctor the next day and
he sent me over to the hospital to get
one of those fancy X-rays with dye
in your veins. Anyway, the X-ray
showed that the stone had passed,
and I have had no problems since
then. Gosh Doc, I've got a job interview in the morning, and I have to
have a current second-class medical
to even get in the door! This isn't going to delay things is it?"

I explained that normally I would
have to see a copy of the X-ray report
to verify all this, but in this case, I
would let him have a certificate that
day if he would promise to have that
report in my hands the next day. He
promised that as soon as the job interview was over, he would comply
forthwith. He was a man of his word.
The next day, he came to the
clinic, smiling from ear to ear. He had
gotten the job and he also had the
records from his previous bout with
renalithiasis. The radiologist's report
of the IVP showed conclusively that
he had passed the stone.
I would like to think I had been
compassionate and that I did the
right thing. I would like to think that,
but I can't. The IVP showed two additional stones in the left renal pelvis. I was extremely lucky that everything turned out all right. He wasn't
due to begin his new job for several
weeks, so he opted to have lithotripsy
in the interim, and we managed to
get him recertified shortly thereafter.
What if he had taken to the skies
and had an attack of acute renal colic?
The point is ...verifyTHEN certify.
The reverse is sometimes tempting,
but it can lead to a real scare (or
worse!).
Another variation of trying to put
you on the spot is the "out of the
blue" phone call. "Doc, I have a
friend who just had a bypass. Does
he have to report that to the FAA?"
asked the caller.
"Well, of course," I replied. So far
so good. But then the caller said.
"Well, this friend also asked me what
would happen if he didn't report it
on his next flight physical. What can
you tell me about that?"
I went into the standard diatribe
about fraudulently filling out a government document, and then it sudContinued —>
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denly dawned on me to mention that
the scar would prompt some pretty
tough questions at the physical exam.
"Well, Doc, he's got a year and
eight months left on his third-class
physical (funny how he knew to the
month the duration of this friend's
physical) so he's OK 'til then, right?"
was the next question.
"No, not right," I replied, "Read
Part 61.53..."
"OK Doc, thanks a lot," concluded the conversation.
One year and eight months later,
a 54-year-old private pilot, who had
been getting his flight physicals with
me for years, attempted to obtain
third-class certification with a fellow
AME. He reported no health problems, but did have a curious mid-sternal chest scar that he had cleverly attempted to conceal with an elaborate
chest tattoo.
The lesson, of course: People will
do anything for certification. No one
loves flying half so much as the
grounded pilot. The majority of pilots will go to great lengths to comply with FAA medical reporting requirements. But, there are a few who
will go to equally great lengths to
conceal a serious problem. Watch for
these few! Very often these types will
call an AME "out of the blue and ask
if this or that condition or medication is approved." Armed with the
latest scoop, they will visit another
AME and fill out their paperwork
accordingly.
Another easy goof-up is the pilot
suffering from Historipenia, the poor
historian. Consider the pilot with
gingival hyperplasia. He presented
with a "clean" history. That is, there
were no "yes" answers on items 17,
18, or 19. He took no medicines and
had no medical encounters. Since he
was 66 years old, I asked him about
his history. He said that everything
was fine: i.e., no hospitalizations, no
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serious illnesses, etc. I asked him
about his gingival hyperplasia. "No
medicines," he said.
I was about ready to chalk this one
up to some sort of gum anomaly and
go ahead and certify. But something
prompted me to ask if he'd ever seen
a dentist about his gums. He replied,
"Nope, this gum problem has been
with me since I was in my twenties.
They say it's from my Dilantin."
But you said no medicines," was
my immediate response.
"Well, Doc, I guess technically
Dilantin is a medication but I've been
taking it for 40 years."
"Oh," is all I could muster at this
point.
I won't bore you with the rest of
the details. The gentleman is happy.
He flies with his son who is a commercial pilot, and who, of course,
assumes pilot-in-command duties. As
hard as it may be to believe, I think
the omission was honest.
I have run into this same scenario
several times with insulin, antihypertensives, and antidepressants.
Many people who have been taking
a specific medication for a long time
(usually for some chronic condition)
will fail to report it. This is not because of any attempt to deceive, but
because they simply don't think of it.
Well, these are the ones I've detected. How many have I missed? I
hope not many. The potential tragedy of even one medically-related accident is horrible, of course. The dividing line between flight safety and
freedom to fly is not an easy one to
draw, nor can it always be drawn with
precision. Many pitfalls await us, so
we must be ever vigilant.
FP
Author's note: This piece appeared in
the Fall of 1966. I resubmit it herewith because I believe that each "new
generation" of AMEs goes through
these pitfalls— and many more.

ELECTIVE from page 1

course as a ten-week elective. The
students could be in any year of
their training, as the course had no
prerequisite requirements. Thus,
the first aerospace medical elective
in Arizona was born.
For course materials, I utilized a
variety of videos, Power Point presentations, and handouts. I had
accumulated most of these items
while teaching at Embry-Riddle
Aeronautical University and lecturing as a safety counselor for the
FAA. I added useful information on
flight physiology and aviation
safety from the Aerospace Medical
Association's Web site, as well as articles from the "Blue Journal." Pertinent, interactive case studies reinforced the new knowledge and
maintained the student's attention.
We began the program by providing some background information on aviation and aerospace
medicine history. We reviewed
available residency programs and
current requirements to obtain
board certification. Case studies
helped the students integrate textbook information with real-life
situations, especially when we covered the physiological and psychological effects that space travel can
have on the human body. We discussed how the musculoskeletal,
vestibular, and cardiovascular systems are affected by the zero-gravity environment. They left with an
in-depth understanding of conditions that can elicit hypoxia, hypoglycemia, hyperventilation, decompression sickness, and many
others, and how the symptoms may
present in the flight environment.

Continued on page 7
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CAMA Members Recognized for Achievements
at 2003 Aerospace Medical Association Meeting
AsMA President Dr. Claude
Thibeault (left) presents the Won
Chuel Kay Award to Dr. Finkelstein.

WON CHUEL KAY AWARD
Sponsored by
The Korean Aerospace
Medical Association
The Won Chuel Kay Award
is presented annually to a
member who has made outstanding contributions to
i n t e r n a t i o n a l aerospace
medicine.
The recipient was SILVIO
F l N K E L S T E I N , M.D. (Past

President of CAMA).

THEODORE C. LYSTER
AWARD
Sponsored by
Lockheed Martin Space
Operations

New AsAAA Fellows.
Above: Dr. Hansrote and Dr. Claude
Thibeault
Left: Dr. Wolbrink and Dr. Claude
Thibeault

The Theodore C. Lyster
Award is given for o u t standing achievement in
the general field of aerospace medicine.
The recipient was GLAUS
CURDT-CHRISTIANSEN,
M.D. (Honorary CAMA
Member).
FELLOW, AEROSPACE
MEDICAL ASSOCIATION
Two CAMA members were
elected Fellow in the Aerospace Medical Association.
They were RONALD W.
HANSROTE, M.D., and ALEX
M. WOLBRINK, M.D.

Theodore C. Lyster
Award Recipient.
Dr. Claus CurdtChristianszen and Dr.
Claude Thibeault

June 2003
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ELECTIVE from page 5
One class was dedicated to the
anatomy and physiology of vision
and hearing, and how it could be
affected in flight by hypoxia, fatigue, and alcohol. We covered visual illusions— i n c l u d i n g the
black-hole effect, white-out effect,
and landing illusions. Another class
was dedicated to studying cockpit
resource management, in-flight
medical emergencies, and what
medical equipment one might expect to find on board a commercial
airliner. We discussed the possible
costs of a medical diversion.
I presented accident scenarios
and actual cases from the NTSB
files on airplane crashes involving
disorientation and situational
awareness. The students (and the
instructor) were amazed at the fre-

quency of accidents that involved
CFIT (controlled flight into terrain) due to lost situational awareness. This helped them understand the limitations of human
anatomy and physiology in the
flight environment.
I stressed the complex interaction between our visual, vestibular,
and proprioceptive systems and
their importance as it relates to orientation. We explored the possible
consequences to a pilot who is impaired by hypoxia, fatigue, dehydration, or over-the-counter medications. I showed the students a short
video on pilots who met their fate
due to the graveyard spiral, and
other somatogravic illusions.
Throughout the classes, I tried
to relate basic anatomy and physiology to the flight environment.
For example, after discussing nor-

HONORARY LIFE
MEMBERSHIP

CIVIL AVIATION
MEDICAL ASSOCIATION
Awarded to

GORDON BETHUNE
For his leadership and integrity in the airline industry,
commitment to employees, and his years of dedicated service
to the flying public in promoting aviation safety for
passengers and crews. He is truly a pilot's pilot.
Awarded May 5, 2003
By the
Board of Trustees
Civil Aviation Medical Association

mal sleep cycles, we then discussed
circadian dysrhythmia and how insomnia and fatigue might affect
performance in flight.
The remaining classes covered
aviation medical topics. We reviewed medical risks associated
with air travel including: cabin air
quality, communicable diseases,
cosmic radiation, air rage, venous
thromboembolism, and bioterrorism.
The last class discussed the general health of pilots and the medical certification process. We reviewed an 8500-8 form and listed
conditions that could disqualify
airmen from becoming FAA-certified. The students ended the course
with a 100-question, written, takehome test.
The students have given tremendously positive feedback. Two students have already requested clinical
rotations in aerospace medicine this
summer. I am currently looking for
facilities that will be able to provide
them with practical experience.
I would like to share this curriculum with any CAMA members
who are interested in teaching this
course. As this is an original outline and my first attempt at teaching this topic, suggestions for improvement are welcome.
I've enjoyed this new teaching
experience and look forward to my
next class. It has been exciting to
see so many young physicians share
my interest in this field. I agree with
Dr. Dodge— It is good for our organization and our profession as a
whole to educate our medical students to ensure that the aerospace
medical community will continue
to grow.
FP
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FROM THE FLIGHT LINE

Fatigue Issues for Flight Crews
BY MARK BURMAN, PILOT- AMERICA WEST AIRLINES
How do flight crews and airlines prevent fatigue-related risks?
A commercial pilot gives the low-down.

B

TIGUE ISSUES for flight crews
ave existed almost since the
awn of time. Over the
_, ears, both aviators and the
medical professionals that certify
them as being fit to fly have become
more and more aware of the negative consequences that can occur
while pilots operate aircraft in a fatigued state.
In recent years, as the science of
fatigue has advanced, terms like
MSOT (missed sleep opportunity)
and WOCL (window of circadian
low) have surfaced to describe periods where fatigue might be prevalent. In the airline business, we use
other terms to describe potentially
fatiguing flights. Terms are used
like Flip-Flop, Redeye, and the
newest one, Black Flag (which is
used to describe a set of flights conducive to fatigue). Whatever you
call them, the risk factors increase
for pilots operating these flights.
So how do flight crews and airlines prevent fatigue-related risks?
At the airline where I fly, there is a
big difference of opinion between
the pilot group and management on
this issue. While management has
a written policy on fatigue and
safety, in practice it appears that
their commitment only goes as far
as the pen. Let me give some examples of what I mean.
The written policy is that when
pilots feel fatigued enough that they
are not safe to fly, they are required
to immediately call Scheduling and

get themselves replaced. Here is
were problems start at my airline.
Under our current contract, if a
pilot "calls in fatigued," they will
be removed from the flight or
flights, but will not be pay protected. Yes, if you call in fatigued,
you lose pay.
For many, this a very strong incentive NOT to make the call. In
truth, most pilots will call in sick
(as there is pay protection in doing
this) rather than call in fatigued,
or they will just fly the pairing fatigued. The company continues to
make the argument that the trips
(or pairings as we refer to them) are
not fatiguing, as evidenced by the
very low number of fatigue calls.
Despite all of the data on sick
calls and a study showing that over
90% of our pilot group has flown
fatigued, the company stands behind its belief that a fatigue problem does not exist. They continue
to cite the policy on calling in fatigued. The study of pilots also
showed that about the same percentage, 90%, have fallen asleep
while acting as a crew member
while airborne.
Additionally, an equally large
percentage indicated that they coordinate naps with other crew
members on flights where fatigue
is an issue. The company's response
to this data was, for the most part,
to question its validity.
The subject of fatigue is not germane to operations at my airline.

Every major airline deals with this
problem. Some attempt to mitigate
the effects of fatigue in late-night
flyers by scheduling only one leg.
For instance, on a late-night
flight from Los Angeles to Boston,
the crew would have no other
flights that day. At my airline, it is
common to start your day at around
7:00 p.m. and fly three legs. The
first from City A to B, next from B
to C, finally from C to D. The
flight from C to D is a late-night
flight from the Western US to the
East Coast.
This is the type of pairing called
a black flag pairing. To alleviate the
fatigue factor, our pilot representatives have consistently asked that
the first two flights are flown by one
crew and the late-night flight done
by another.
The company has maintained for
some time that if the flight or
flights comply with FAA regulations, then it is OK. From time to
time, we see improvements; however,
economics seem to dominate, and
the black flag pairings continue.
Here is some more data to reflect on. At my airline, 27% of the
trips assigned fly through a WOCL.
Additionally, 50% of the trips assigned are identified as pairings,
including MSOT. These numbers
are derived using established criteria from NASA studies, as well as
leading industry standards for fatigue criteria.
FP
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For the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR)
in patients 12 years of age and older, as well as for the symptomatic relief of pruritus, reduction in the number
of hives, and size of hives, in patients with chronic idiopathic urticaria (CIU) 12 years of age and older

When treating SAR, PAR, and CIU, prescribe...

Powerful relie
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With an excellent safety profile
I Nonsedating—no precautions regarding activities
requiring mental alertness
I Safe for use in seasonal allergic rhinitis patients
with concomitant mild to moderate asthma
• No clinically relevant drug interactions or effects on QTC
— In studies with erythromycin, ketoconazole, azithromycin,
fluoxetine, and cimetidine
I Neither food nor grapefruit juice affected bioavailability
I The FAA medically qualifies pilots and air traffic controllers
using the product under special conditions
In allergic rhinitis, the most commonly reported adverse
events included pharyngitis (4.1%, placebo 2.0%),
dry mouth (3.0%, placebo 1.9%), and fatigue (2.1%,
placebo 1.2%).

(desloratadine)
Please see brief summary of Prescribing Information on following page.

In chronic idiopathic urticaria, the most commonly
reported adverse events included headache
(14%, placebo 13%), nausea (5%, placebo 2%),
and fatigue (5%, placebo 1 %).
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CLARINEX®
(desloratadine)
TABLETS
Brief Summary (For full Prescribing Information, see package insert.)
INDICATIONS AND USAGE: Allergic Rhinitis: CLARINEX Tablets 5 mg are indicated for the relief of the nasal and non-nasal symptoms of allergic rhinitis (seasonal
and perennial) in patients 12 years of age and older.
Chronic Idiopathic Urticaria: CLARINEX Tablets are indicated for the symptomatic
relief pf pruritus, reduction in the number of hives, and size of hives, in patients with
chronic idiopathic urticaria 12 years of age and older.
CONTRAINDICATIONS: CLARINEX Tablets 5 mg are contraindicated in patients
who are hypersensitive to this medication or to any of its ingredients, or to loratadine.
PRECAUTIONS: Carcinogenesis. Mutagenesis, Impairment of Fertility: The carcinogenic potential of desloratadine was assessed using loratadine studies. In an
18-month study in mice and a 2-year study in rats, loratadine was administered in
the diet at doses up to 40 mg/kg/day in mice (estimated desloratadine and desloratadine metabolite exposures were approximately 3 times the AUC in humans at the
recommended daily oral dose) and 25 mg/kg/day in rats (estimated desloratadine
and desloratadine metabolite exposures were approximately 30 times the AUC in
humans at the recommended daily oral dose). Male mice given 40 mg/kg/day
loratadine had a significantly higher incidence of hepatocellular tumors (combined
adenomas and carcinomas) than concurrent controls. In rats, a significantly higher
incidence of hepatocellular tumors (combined adenomas and carcinomas) was
observed in males given 10 mg/kg/day and in males and females given
25 mg/kg/day. The estimated desloratadine and desloratadine metabolite exposures
of rats given 10 mg/kg of loratadine were approximately 7 times the AUC in humans
at the recommended daily oral dose. The clinical significance of these findings during long-term use of desloratadine is not known.
In genotoxicity studies with desloratadine, there was no evidence of genotoxic
potential in a reverse mutation assay (Sa/monella/E. co/i mammalian microsome
bacterial mutagenicity assay) or in two assays for chromosomal aberrations
(human peripheral blood lymphocyte clastogenicity assay and mouse bone marrow
micronucleus assay).
There was no effect on female fertility in rats at desloratadine doses up to
24 mg/kg/day (estimated desloratadine and desloratadine metabolite exposures were
approximately 130 times the AUC in humans at the recommended daily oral dose). A
male specific decrease in fertility, demonstrated by reduced female conception rates,
decreased sperm numbers and motility, and histopathologic testicular changes,
occurred at an oral desloratadine dose of 12 mg/kg in rats (estimated desloratadine
exposures were approximately 45 times the AUC in humans at the recommended
daily oral dose). Desloratadine had no effect on fertility in rats at an oral dose of 3
mg/kg/day (estimated desloratadine and desloratadine metabolite exposures were
approximately 8 times the AUC in humans at the recommended daily oral dose).
Pregnancy Category C: Desloratadine was not teratogenic in rats at doses up to
48 mg/kg/day (estimated desloratadine and desloratadine metabolite exposures
were approximately 210 times the AUC in humans at the recommended daily oral
dose) or in rabbits at doses up to 60 mg/kg/day (estimated desloratadine exposures
were approximately 230 times the AUC in humans at the recommended daily oral
dose). In a separate study, an increase in pre-implantation loss and a decreased
number of implantations and fetuses were noted in female rats at 24 mg/kg (estimated desloratadine and desloratadine metabolite exposures were approximately
120 times the AUC in humans at the recommended daily oral dose). Reduced body
weight and slow righting reflex were reported in pups at doses of 9 mg/kg/day or
greater (estimated desloratadine and desloratadine metabolite exposures were
approximately 50 times or greater than the AUC in humans at the recommended
daily oral dose). Desloratadine had no effect on pup development at an oral dose of
3 mg/kg/day (estimated desloratadine and desloratadine metabolite exposures were
approximately 7 times the AUC in humans at the recommended daily oral dose).
There are, however, no adequate and well-controlled studies in pregnant women.
Because animal reproduction studies are not always predictive of human response,
desloratadine should be used during pregnancy only if clearly needed.
Nursing Mothers: Desloratadine passes into breast milk, therefore a decision
should be made whether to discontinue nursing or to discontinue desloratadine,
taking into account the importance of the drug to the mother.
Pediatric Use: The safety and effectiveness of CLARINEX Tablets in pediatric
patients under 12 years of age have not been established.
Geriatric Use: Clinical studies of desloratadine did not include sufficient numbers
of subjects aged 65 and over to determine whether they respond differently from
younger subjects. Other reported clinical experience has not identified differences
between the elderly and younger patients. In general, dose selection for an elderly
patient should be cautious, reflecting the greater frequency of decreased hepatic,
renal, or cardiac function, and of concomitant disease or other drug therapy, (see
CLINICAL PHARMACOLOGY - Special Populations).
Information for Patients: Patients should be instructed to use CLARINEX Tablets
as directed. As there are no food effects on bioavailability, patients can be instructed that CLARINEX Tablets may be taken without regard to meals. Patients should
be advised not to increase the dose or dosing frequency as studies have not demonstrated increased effectiveness at higher doses and somnolence may occur.

ADVERSE REACTIONS: Allergic Rhinitis: In multiple-dose placebo-controlled trials, 2,834 patients received CLARINEX Tablets at doses of 2.5 mg to 20 mg daily,
of whom 1,655 patients received the recommended daily dose of 5 mg. In patients
receiving 5 mg daily, the rate of adverse events was similar between CLARINEX and
placebo-treated patients. The percent of patients who withdrew prematurely due to
adverse events was 2.4% in the CLARINEX group and 2.6% in the placebo group.
There were no serious adverse events in these trials in patients receiving desloratadine. All adverse events that were reported by greater than or equal to 2% of
patients who received the recommended daily dose of CLARINEX Tablets (5.0 mg
once-daily), and that were more common with CLARINEX Tablet than placebo, are
listed in Table 5.
Table 5
Incidence of Adverse Events Reported by > 2% of Allergic Rhinitis
Patients in Placebo-Controlled, Multiple-Dose Clinical Trials
CLARINEX Tablets 5 mg
Placebo
Adverse Experience
(n=1,655)
(n=1,652)
Pharyngitis
4.1%
2.0%
Dry Mouth
3.0%
1.9%
Myalgia
2.1%
1.8%
Fatigue
2.1%
1.2%
2.1%
Somnolence
1.8%
2.1%
Dysmenorrhea
1.6%
The frequency and magnitude of laboratory and electrocardiograph^ abnormalities were similar in CLARINEX and placebo-treated patients.
There were no differences in adverse events for subgroups of patients as defined
by gender, age, or race.
Chronic Idiopathic Urticaria: In multiple-dose, placebo-controlled trials of chronic
idiopathic urticaria, 211 patients received CLARINEX Tablets and 205 received
placebo. Adverse events that were reported by greater than or equal to 2% of
patients who received CLARINEX Tablets and that were more common with
CLARINEX than placebo were (rates for CLARINEX and placebo, respectively):
headache (14%, 13%), nausea (5%, 2%), fatigue (5%, 1%), dizziness (4%, 3%),
pharyngitis (3%, 2%), dyspepsia (3%, 1%), and myalgia (3%, 1%).
The following spontaneous adverse events have been reported during the marketing of desloratadine: tachycardia, and rarely hypersensitivity reactions (such as
rash, pruritus, urticaria, edema, dyspnea, and anaphylaxis), and elevated liver
enzymes including bilirubin.
DRUG ABUSE AND DEPENDENCE: There is no information to indicate that abuse
or dependency occurs with CLARINEX Tablets.
OVERDOSAGE: Information regarding acute overdosage is limited to experience
from clinical trials conducted during the development of the CLARINEX product. In
a dose ranging trial, at doses of 10 mg and 20 mg/day somnolence was reported.
Single daily doses of 45 mg were given to normal male and female volunteers for
10 days. All ECGs obtained in this study were manually read in a blinded fashion by
a cardiologist. In CLARINEX-treated subjects, there was an increase in mean heart
rate of 9.2 bpm relative to placebo. The QT interval was corrected for heart rate
(QTC) by both the Bazett and Fridericia methods. Using the QTC (Bazett) there was a
mean increase of 8.1 msec in CLARINEX-treated subjects relative to placebo. Using
QTC (Fridericia) there was a mean increase of 0.4 msec in CLARINEX-treated subjects relative to placebo. No clinically relevant adverse events were reported.
In the event of overdose, consider standard measures to remove any unabsorbed
drug. Symptomatic and supportive treatment is recommended. Desloratadine and
3-hydroxydesloratadine are not eliminated by hemodialysis.
Lethality occurred in rats at oral doses of 250 mg/kg or greater (estimated desloratadine and desloratadine metabolite exposures were approximately 120 times the
AUC in humans at the recommended daily oral dose). The oral median lethal dose
in mice was 353 mg/kg (estimated desloratadine exposures were approximately
290 times the human daily oral dose on a mg/m2 basis). No deaths occurred at oral
doses up to 250 mg/kg in monkeys (estimated desloratadine exposures were
approximately 810 times the human daily oral dose on a mg/m2 basis).
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Chronotherapeutics in Aviation Medicine
Circadian Variance and the Aviator
BY JAMES R. ALMAND, M.D.

One hour of sleep before midnight is worth two after.
—Ancient Proverb

S

LEEP LOSS— sleep deprivation,
or "sleep debt" —can affect
one's reaction time, attention,
cognition, physiology, memory, and
alert status. This change can be
acute in the sleep-deprived individual or it can be insidious.
All individuals react differently
to sleep times (e.g., from Dr. Alfred
Sweitzer, who averaged four hours
nightly to today's studies of eight
hours' recommended sleep). Some
individuals suffer neurobehavioral
changes from sleep loss differently
from others. Lost sleep has a cumulative effect and accumulates as
sleep debt.
Insomnia includes complaints of
difficulty initiating sleep, maintaining sleep, resuming sleep, or unrefreshing sleep. Impairment in
functioning, fatigue, or somatic
symptoms can follow. Insomnia is
categorized as transient (a few
days), short term (longer — from
significant stressors), and long term
(months or years - from medical
of psychiatric cause). Untreated
sleep disorders can also be associated with medical problems, such
as heart disease, hypertension, and
strokes.
Insomnia therapies in use today
include older hypnotics (benzodiazepines), which can cause abuse
potential, hangover, impairment,
dizziness, and memory impairment.
More recent changes in hypnotics
evolved in the non-benzodiazepine
varieties, which offer greater safety
and fewer side effects, with far fewer

residual effects than benzodiazepines
— zolpidem (Ambien) and zaleplon
(Sonata) are in this class and produce
sedation through a neurochemical effect on the brain's GABA-a receptor.
Better prescribed normal sleep patterns are an advantage of these newer
medications, with minimal side effects, tolerance rebound, and psychomotor performance.
Other non-prescribed sleep aids
include antihistamines (Unisom,
Benadryl, Nytol, Sleep Eze,
Sominex) and also herbs (valerian
and melatonin). Many studies to
date suggest that antihistamines
and herbs are associated with longterm hangover and metabolic/hepatic side effects.
Medical theories in the past
taught the concept that bodily
function was constantly in equilibrium throughout the 24-hour day.
Experience developed in the careful study of circadian variance, both
in travel ("jet lag") or in one's own
biological clock, now has revised
that theory.
The human brain has an indwelling "pacemaker" for circadian
clock dependent alerting, which
resides in the suprachiasmatic
nucleus of the hypothalamus. This
endogenous biologic clock coordinates the body's sleep and wakening cycle. Lack of synchronism of
the h u m a n biologic clock (or
desynchronosis) develops when the
brain's circadian rhythm is out of
phase with the environment — and
termed "jet lag." Individuals adjust

to desynchronosis at differing levels, with variable tolerance to circadian changes.
In the human body, cyclical biologic functions are also tied to the
timing of drug administration for
achieving maximum physiologic
benefit. Timing of medication dosage in clinical aviation — civilian or
military — is vital to the aviator's
biologic cyclical circadian rhythm.
Examples of timing of drug dosages
to circadian bodily clocks are noted
in many aspects — e.g., diseases and
drugs such as anticoagulants, cholesterol lowering medications, asthma
therapies, arthritics, antihypertensives, and anginal medications.
Circadian early-morning awakening is closely tied to bodily physiological surges in blood pressure,
pulse, cortisol and catecholamine
levels, increased platelet aggregation, increased myocardial oxygen
demand, testosterone elevation, and
even blood viscosity.
Human diseases also exhibit circadian variances and historically
relate exacerbation of primary occurrences to the time of day or
night — e.g., epilepsy, myocardial
infarction, cardiac arrest, strokes,
migraine, early morning contrasted
with nighttime asthma, apnea, and
congestive heart failure, or daytime
hemorrhagic gastric ulceration, or
hypertensive emergencies.
The aviator faces circadian
changes in all flights that interrupt
Continued —>
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the individual's regular biologic
clock— early departures, overnight
flights, or short layovers before the
next starting "show." Add to this
the "phase advance" of travel circadian factors is more notable in
flights to an eastern direction, causing increase in jet lag in traveling
east related to the brain's light-dark
melatonin cycle. This form of jet
lag results in increased sleepiness,
insomnia, fatigue, and gastrointestinal problems, and it is more notable than in western travel.
On layovers, the flyer must learn
to accommodate his body to a
strange hotel, an early time to sleep
based on the next day's flight show,
daytime sleep, night-time or departure from a region distant by miles
and multiple time zone changes
from his domicile, and many other
personal or schedule-determined
factors — all of which pose a challenge to gain a satisfactory eight
hour required sleep or a satisfactory
flight performance the following day.
In aviation medicine, flight
crews have repeatedly discussed the
value of circadian bodily demands
in the flyer. Many flight crews, in
recognition of this factor commonly employ sleep assistance
drugs or herbs (Nytol, Stilnox,
Benadryl, chamomile, Kava Kava,
etc.), which are frequently secured
from overseas drug sources or prescribed by their private physicians.
In many instances, this usage of
"sleep aids" is unknown or overlooked (or accepted) by the flyer's
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flight surgeon and this not entered
on the FAA's 8500 form. The safety
of this practice in aviators has
drawn the attention of the FAA and
the flight surgeon community, and
it can be an unacceptable practice.
Couple the above self-medication
for sleep to the use the following day
for stimulants (caffeine, etc.) - there
is a "triple-armed" concern in aviation medicine interest regarding
"circadio-aviation" in all flyers' therapeutic use of medications.
Consider the stimulant use ("go
pill") in the varied m i l i t a r i e s
(Faulkland campaign, Afghanistan
war, etc.) as a defined positive factor in troop or aircrew performance
- this controlled medication regimen has strong historical evidence
of positive performance outcomes.
But certainly, such a practice of
controlled stimulants use in commercial aviation is highly disapproved — plus would ring a lot of
bells in a random drug screen.
What is the human's limit to biologic variance in time zone changes,
sleep deprivation, alteration in the
circadian homeostasis of human
physiology (or psyche), the use of
stimulants or stressors, or even use
of prolonged drug delivery systems
that function with plasma drug levels over 24 hours?
Many questions still are unresolved regarding the human physiology of bodily sleep cycle demands
- or alterations of the same. With
longer-duration intercontinental
flights in larger "super jumbo"

'CAMA SUNDAY' SPECIAL EDITION
Photos plus the complete text of the recent San Antonio
scientific program entitled IN-FLIGHT MEDICINE will be presented
in a rare "Extra" issue of the FlightSurgeon...com'mg soon!
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aircraft occurring and documented
adverse passenger health developments reported (vascular, pulmonary, cardiac, etc), few studies of
flight crew immediate, delayed, or
future health consequences are ongoing — radiation effects of prolonged high-altitude exposure is
but one long-term concern that
demands ongoing research.
Should not a similar concern be
present regarding chronic circadian
physiologic changes affecting flight
crews?
Today's challenge to the commercial aviation community — and
their flight surgeons - is to better
educate the flyer concerning aspects
of long flight legs, insomnia or
circadian-induced issues, symptoms
of sleep deprivation, commonly
available "sleep aids," hazards of
hypnotics for sleep, FAA guidelines
on the subject, and (by all means)
actively participate in preventive
medicine for all pilots. Only in this
way can flight medicine accomplish
its true mission - keeping the flyer
healthy.
Currently, transient insomnia in
the aviator requires no treatment,
with usually only sleep hygiene
training being effective, but the
pilot population requires special
consideration in choosing any agent
for sleep improvement, due to their
requirement for a high degree of
alertness on awakening.
FP

Visit CAMA's Web Site
www.civilavmed.com
Suggestions and
contributions are
welcome, so visit the site
and give us your
opinions.
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Complexity and Safety
BY CHARLES E. BILLINGS, MD, THE OHIO STATE UNIVERSITY, COLUMBUS, OHIO

A viation is a very complex, highly distributed, highly dynamic domain similar to medicine.
Both domains are comprised of many diverse groups and individuals with agendas often in
competition. Both domains involve very real dangers for consumers.

I

HAVE BEEN ASKED to dlSCUSS
complexity and safety in rela
tion to health care. For over 40
years, I have worked to improve
aviation safety, both as a physician
and as a human factors specialist.
In 1997, 1 became involved in attempts to improve patient safety.
Your hosts have asked me to discuss our work in adverse event reporting and how it might be applied in the medical domain.
Aviation is a very complex, highly
distributed, highly dynamic domain.
It is rather similar to medicine, which
also is complex, highly distributed
and highly dynamic. Both domains
are comprised of many diverse groups
and individuals with agendas that are
often in competition. Both domains
involve very real dangers for consumers. The products produced by both
domains are essential and in both,
there has been continually increasing
demand for services.
Interestingly, each system has only
one major product. In aviation, that
product is the transport of people and
goods from one place to another. In
medicine, the product is the delivery
of services to enhance, maintain, or
restore health. All of the resources and
people in each system are devoted
more or less directly to delivering that
one product, and doing so economically, for both systems operate in demand-based markets.
These two systems have been dramatically affected by the introduction
of a great deal of high technology. As
a result of organizational, managerial, and technical advances, both
domains have become increasingly
opaque, even to the experts within
them. This has been an almost inevitable concomitant of increasing

complexity in many industries and,
I should say, in government as well.
Perrow, in 1984, pointed out that
accidents are normal under these conditions. He wrote,
Our ability to organize (and manage) does not match the inherent
hazards of some of our organized
activities. Better organization will
always help any endeavor. But the
best is not good enough for some
activities we have decided to
pursue, (p. 10)
In other words, increasing complexity and system opacity are threats
to system safety. Your problem, as
system managers, is to accomplish
four major tasks to:
• understand the system (or systems) for which you are responsible;
• understand how that system is
supposed to behave u n d e r all
conditions;
• understand how that system can
misbehave; and
• learn how to avoid or ameliorate
unwanted system behavior.
This is a tall order. You are ultimately responsible for the safe, efficient delivery of your product—even
though you may not have the knowledge and skills to provide medical
care, just as most airline CEOs cannot either pilot or maintain their aircraft and other tools.
You are hindered in these tasks by
what Sydney Yoshida called "The Iceberg of Ignorance." His work suggests that the following percentages
of an organization's operational problems are known to:
• Top managers: About 4%
• Middle managers: About 9%
• Supervisors: About 74%
• Front-line employees: Nearly 100%
In the 1999 revision of his book,

Normal Accidents, Perrow asks a question that gets to the heart of learning
about safety problems in very complex organizations:
How can we create the atmosphere, the culture, that will allow
underlings to speak up, or copilots
to warn chief officers; get operators to see the whole system rather
than just their part of it; keep the
watcher of the autopilot alert ... ?
(p. 378)
Dr. Perrow, an organizational sociologist, has neatly captured the reason for establishing the NASA Aviation Safety Reporting System.
What is the prevailing culture now
with respect to adverse events and
outcomes? Most people, I think, still
feel that punishment for serious errors is an appropriate way to enforce
our society's attempts to maintain a
safe and healthful environment for
its citizens.
David North expressed this viewpoint in an editorial last year in Aviation Week and Space Technology, called
"Let (the) Judicial System Run Its
Course in Crash Cases." He said in
Part, "NTSB Chairman James Hall
has visited the U. S. Attorney
General's Office in Washington many
times to discourage prosecutors from
attempting to find criminal fault
while the board, industry and pilot
organizations are still trying to determine the cause of an accident. Hall
and others contend that if blame or
threat of litigation is allowed to move
to the fore, people will be afraid to
talk to accident investigators. And
that will hinder the fact-finding that
is aimed at preventing similar crashes.
Hall is worried that the lawyers are
getting out of hand...
Continued —>
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However, I believe that the failure of SabreTech employees to put
caps on oxygen generators constituted willful negligence ... Prosecutors were right to bring charges.
There has to be some fear that not
doing one's job correctly could lead
to prosecution. Aviation is not and
should not be exempt from legal
due process...
One would hope that attorneys
representing the survivors of an accident would not get in the way of
a safety investigation ... At some
point, the legal world may start to
interfere with the overarching goal
of improving safety ... For now,
though, the safety board should not
overreact to the Valujet criminal
prosecutions and upset the balance
of safety and blame. This would be
unfortunate because the NTSB and
judicial system have all of the necessary tools to help aviation safety,
if they use them with wisdom.
(Unfortunately, they do not.)
Human Error Issues
The concept of human error as
causation implies that human error
is blameworthy, as expressed by Mr.
North in the aviation context, and
by the Institute of Medicine when it
said in its Executive Summary, "the
external environment should create
sufficient pressure to make errors costly
to health care organizations and providers, so they are compelled to take
action to improve safety."
I contend that this concept is
counterproductive because it can inhibit our efforts to understand the
real causes of unwanted occurrences.
But what should replace it? The IOM
spoke to the issue of understanding
immediately after the assertion cited
above: "At the same time, there is a
need to enhance knowledge and tools
to improve safety and break down
legal and cultural barriers that impede safety improvement." Let me
suggest that it is very likely that this
need will not be satisfied if the previously expressed need (making errors
costly to compel action to improve
safety) is our primary goal. Why do
I think this is true?
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It has been my experience that the
greatest "legal and cultural barrier"
to efforts to improve our understanding of unwanted events is the culture
of blame, punishment and retribution that pervades our society and
which is now becoming even more
manifest in the criminalization of
professional (e.g., pilot, physician,
nurse) behavior when it is associated
with adverse events. It is noteworthy
that the pilot of an airline aircraft that
crashed while carrying out an instrument approach in New Zealand in
1995 has just been tried (and fortunately acquitted) on four manslaughter charges. The police secured the
cockpit voice recorder tapes through
the courts for its investigation, the
first time that this has happened. Can
you believe that this misuse of safetycritical data will improve the climate
for aircraft accident investigation in
that nation?
I have come to believe that you
can't have it both ways. You can mandate the reporting of adverse events,
then count and categorize them,
eliminate either the people or the behaviors associated with them, then
observe whatever improvement you
can find in your "error" counts, as
the IOM has recommended. Alternatively, you can take the imperfect
world as you find it, solicit voluntary
reports of incidents, use them as opportunities to learn about their processes and causes, and focus your
remediation efforts on the system in
which errors occur.
This approach led us to develop a
voluntary, confidential, non-punitive
incident reporting system that for 25
years has brought to light undesired
behaviors and unwanted occurrences
in aviation, in order to learn what
latent and manifest factors were involved in those incidents.
Incident Reporting as a Source of
Information and Learning
I do not advocate an "enlightened,
blame-free, humane approach to collecting data about unwanted events"
for any philosophical reason. I
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advocate confidential, voluntary reporting of adverse events simply because I know it works when the collection and analysis system is designed properly and implemented
sensitively. Because it works, it can
lead knowledgeable people like yourselves to the information, insights,
and knowledge that you must have
to effect the improvements that politicians and society are demanding in
health care, largely as a result of the
IOM report. I should point out that
a similar hue and cry was raised by
the Congress and the public after the
crash of TWA flight 514 in 1974, and
that f uror led to our NASA team
being tasked to develop our Aviation
Safety Reporting System.
Figure 1 [see model, next page]
shows a model of the incident reporting system that we developed and are
still using to collect incident data in
civil aviation in the United States. I
believe strongly that incident reporting, analysis and interpretation must
follow some sort of closed loop
model like this in order to keep the
industry and its practitioners motivated to use it to share the information they have.
Some important "first principles"
are embodied in this concept as realized in the NASA Aviation Safety
Reporting System. I describe them
briefly because I think each is essential to the success of a voluntary adverse event reporting system. They
include:
• The aviation community are the
stakeholders in an Incident Reporting System.
The aviation community has been
deeply involved in the design, implementation and use of our incident
reporting system since its inception
in 1975. Community representatives
act as a "board of overseers" and provide criticism, expertise and advocacy
for the system. They and we consider themselves as the primary
stakeholders in the venture, along
Continued —>
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with the Federal Government which
supports our system and makes
heavy use of its data.
• The community are the providers of
information.
Nearly 100% of reporters are from
the pilot, dispatcher, flight attendant,
air traffic controller and aircraft maintenance engineering communities.
These are the occupational groups represented on our advisory committee,
whose members encourage their
groups to report to the system.
• The reporting system must be credible: Its objectivity must be paramount.
The choice of NASA, a research
agency without regulatory or enforcement powers, as the parent organization for ASRS helped the new reporting system to establish a reputation
for credibility and objectivity. Widespread use of its publications has
helped to maintain that reputation
during its 25 years of service to the
community.
• The reporting system must be safe
and non-punitive.
NASA's unique role as a research
agency helped to foster the impression
that data provided to it would not be
misused, but the reporting system
went to considerable lengths to ensure
that this impression was correct. To
our knowledge, there has not been a
security breach in 25 years; none of
the over 500,000 persons who have
submitted reports has incurred personal harm as a result.
• The reporting system must be independent.
It was obvious in 1975 that a voluntary aviation incident reporting system, to be successful, would have to
be independent of the many political
and other pressures that might arise
from its data and conclusions. This
assumption was proven correct when
ASRS released the results of a study
whose conclusions ran counter to the
strongly-held beliefs of its sponsor,
which tried to shut it down by removing immunity from its operations. I
believe now, as I did then, that to be
useful, a reporting system must be able
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Fig. 1.
First Principles of
Voluntary Incident
Reporting
to report its results as
it sees them; it must be
i n d e p e n d e n t of the
many competing interest groups in its community.
• Subject-matter experts classify, analyze &
interpret data.
Since its beginning,
our reporting system has
utilized highly experienced, usually recently-retired, pilots,
controllers and other subject-matter
experts as its analysts, to ensure that
incoming reports are screened by
knowledgeable people who understand the context of the reports. These
persons perform all of the primary
analyses of incoming data, and some
secondary analyses as well when their
insights suggest new avenues of inquiry. Other analyses are done by academic and other experts who utilize
special studies to collect data on topics in which they are interested.
• The community receives ongoing
feedback from ASRS
No one particularly enjoys filling
out reports. It is vital that prospective
reporters see tangible evidence that
their reports are being used constructively to improve safety. ASRS utilizes
many avenues of feedback to practitioners and the aviation industry.
Among its most important feedback
mechanisms are the following.
• ASRS has issued over 1000 Alert
Bulletins
• Callback reaches 85,000 subscribers
each month
• The system has performed over 500
special studies of data
• The system routinely performs
quick-response studies for the NTSB,
FAA, the Congress, and many other
requesters
• DirectLine, a technical publication,
goes to 1800 organizations

Nurralive
reports

Incident reporting
and analysis is
an iterative loop

Learn in z

• The community has been given incentives to continue reporting to ASRS
In addition to disseminating the
results of its studies of incoming reports, other incentives are built into
the system. These are specific to ASRS;
other incentives may be needed in
other contexts.
• Philanthropy: reporters identify
with the ASRS safety mission
• Confidentiality: reporters are protected from identification
• Prophylactic effect: reporters receive
limited immunity from punitive action
• Therapeutic effect: reporters learn
from their errors and share their
insights
Discussion
I believe that these principles are
paramount in the establishment and
maintenance of a voluntary reporting
system within a community which
finds a need for data concerning operational problems and sensitive human factors issues. Such factors are
involved in 70-80% of the incidents
reported to ASRS, and in a roughly
equal percentage of accidents in aviation and other complex domains.
Note that since this is a voluntary,
confidential system, we believe that
our first obligation is to protect all
reporter identities. Does this matter?
Our stakeholders clearly believe it
does. When the FAA established
Continued —>
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voluntary incident reporting as an inhouse activity in 1975, it received
perhaps 200 reports in a year. When
the NASA safety reporting program
replaced it a year later, we received
100 reports a week; this number now
averages 600 reports a week. The
FAA promised the same level of
confidentiality that we did—but it
is the enforcement agency for civil
aviation and it was not trusted by
the community.
We completely deidentify our reports during intake processing, and
some have criticized this step. All processed data from the ASRS are public data; at least one large national
newspaper demands, and receives, the
data on a monthly basis. If the
public's interest is in what is really
going on in the aviation system, they
can find out without much difficulty.
All that they cannot learn from processed data is who reported what,
who was directly involved, and the
exact date and time of an occurrence.
If one's primary interest is in assigning blame or liability for specific occurrences, these data are useless. But
if that is not one's interest, what has
been lost by this approach? The data,

June 2003

and our conclusions, are freely available to all who care to inquire.
Because our system is voluntary,
we cannot evaluate the incidence or
prevalence of such occurrences. More
important, however, the presence of
specific problems in the national aviation system can be reliably inferred if
reports of such problems are received.
We can reasonably assume that the
number of reports of a given type of
occurrence represents a lower bound
for the frequency with which such
problems occur. Is this not what we
need to know to aim our analytic resources toward the most important
problems? Do we really need precise
estimates of their incidence to decide
whether they are worth bothering
with? We have assumed (we think
correctly) that busy people do not
bother to report non-events, and that
our reporters are generally truthful in
their narratives.
Our analysts can contact reporters to ASRS before deidentifying their
reports, and they have done so on
thousands of occasions to obtain further details of the occurrences
reported. These "callbacks" have
made it possible for us to do detailed

studies of problems that represent a
high potential for serious harm. We
often discuss deidentified incidents
with experts who can assess that potential or who can suggest possible
solutions for the problems presented.
We publicize serious reports extensively so that the community knows
of emerging threats and can watch
for them in their operations.
Finally, our analysts represent
several hundred years of aviation
experience. They share what they
are seeing with each other on a
daily basis (and with FAA during frequent teleconferences).
These interactions make the analysts more sensitive to what they
see in incoming reports, and help
to provide insights into possible
causes or remedial actions. This
isn't tidy science, but it has been
quite remarkable in its effectiveness. And effectiveness is what
we are after, not science. FP
This concludes Part I of this article. It
will be concluded in the next issue of
the FlightPhysician. Prepared for the
Premier CEO Leadership Forum, Aspen, Colorado, September 11, 1991.
© Charles E. Billings, MD, 2001

CAMA CONSULTANTS
To our new members and as a reminder to all: This is a list of more experienced AMEs that have volunteered to help
with troublesome certification cases. For involved questions, E-mail or fax is preferred. This list is NOT for use by
airmen, but solely for AMEs within the CAMA membership.
Frank H. Austin, MD
Phone: 703- 471-1769
Fax: 703-450-3104
E-mail: FHAustin@aol.com

EST

A. J. Parmet, MD
CST
Phone: 816-561-3480
Fax: 816-561-4043
E-mail: AJParmet@cysource.com

Charles A. Berry, MD
Phone: 713-978-7755
Fax: 713-978-5001
E-mail: docchuckb@aol.com

CST

Gordon L. Ritter, DO
Phone: 520-776-9830
Fax: 513-751-5660
E-mail: gordon@rittaire.com

MST

A. Duane Catterson, MD
CST
Phone: 281-873-0111
Fax: 281-873-0660
E-mail: cattersib@worldnet.att.net

Robert A. Stein, MD
Phone: 513-751-0080
Fax: 513-751-5660
E-mail: Bobxtein47@aol.com

EST

Marc C. Eidson, MD
CST
Phone: 817-599-9472
Fax: 817- 599-9472
E-mail: MARK@EIDSON.ORG

M. Young Stokes III, MD
Phone 903-465-6707
Fax: 903-465-6744
E-mail: mysiii@flash.net

CST

James L. Tucker, MD
EST
Phone: 256-329-7788
E-mail: JLTucker@mindspring.com
Mark Thoman, MD
Phone: 515-244-4229
Fax: 515-244-1131
E-mail: PARO1795@aol.com

CST

John D. Hastings, MD
Phone: 918-747-7517
Fax: 918-742-7947
E-mail: hastings20@msn.com

CST

H. Stacy Vereen, MD
Phone: 404-761-2166
Fax: 404-761-2168
E-mail: Stacyv@earthlink.net

EST

On The Horizon
FAA Aviation Medical Examiner
Seminar Schedule
2003
July 18-20

Chicago, 111. (Aviation Physiology/HF)

August 1 5 - 1 7

Washington, D.C./McLean, Va. (Cardio)

September 15-19

Oklahoma City, Okla. (Basic)

October 3 - 5

Salt Lake City, Utah (Ophth/Otolaryn/
Endocrin)

November 3 - 7

Oklahoma City, Okla. (Basic)

2004 Basic Seminars
March 15-19

Oklahoma City, Okla.

June 21-25_

Oklahoma City, Okla.

September 13-17

_ Oklahoma City, Okla.

November 15-19

_ Oklahoma City, Okla.

For information, call your regional flight surgeon. To
schedule a seminar, call the FAA Civil Aerospace Medical
Institute AME Programs Office ( 405) 954-4830

CAMA Headquarters
P.O. Box 23864
Oklahoma City, OK 73123-2864

Aerospace Medical Association's
Annual Meeting Schedule
May 2 - 6 , 2004

Anchorage, Alaska

May 8-12, 2005

Kansas City, Missouri

Civil Aviation Medical Association's
Annual Meeting Schedule
October 8-12, 2003 _ Seattle, Washington,
Marriott Sea Tac Hotel
October 6-10, 2004 _ Omaha, Nebraska,
Marriott Omaha Hotel
October 5 - 9 , 2005 _ Charleston, South
Carolina, TEA
October 4 - 8, 2006
Ottawa, Canada,
Ottawa Marriott Hotel

New CAMA Members
Ahmed Elmonem Awad, M.D.
14 Abd El Aziz St. Heliopolis
Cairo, Egypt
Phone: 02-012341436
Aviation Medicine
Matthew Fisher, D.O.
20000 North 57th Ave., #F105
Glendale, AZ 85308-6863
Phone: 623-572-3758
Marco V. Garcia, M.D.
P.O. Box 506
Cibolo, TX 78108-0506
Phone: 210-536-4714
Aviation Medicine

Pilot

Hans Kraus, M.D.
UhelnbuisterWeg55
D-22085 Hamberg, Germany
Aviation Medicine

Pilot

P.J. Marshio, D.O.
P.O. Box 1569
Aransas Pass, TX 78336-1569
Phone: 361-758-1585
General Surgery Pilot
AME

